Specifically in cardiometabolic settings, chronically elevated IL-6 has been associated with central adiposity, insulin resistance, endothelial dysfunction, and increased cardiovascular risk, reflecting sustained activation of adipose and vascular compartments (Tylutka et al., 2024). Here, IL6 is linked to endothelial dysfunction.